TYT-1 is a West Nile virus (WNV) inhibitor exhibiting antiviral activity (IC₅₀ = 0.7 mM) by blocking the pre-assembly replication step following viral entry into cells.
BI-1230 is a potent inhibitor of HCV NS3 protease, exhibiting efficacy in the low nanomolar range, and notably suppresses viral replication. This compound demonstrates high selectivity, distinguishing effectively between other serine/cysteine proteases. Additionally, BI-1230 exhibits favorable pharmacokinetic (PK) properties[1].